Renal Pelvis and Ureter Urothelial Carcinoma
Information
- Disease name
- Renal Pelvis and Ureter Urothelial Carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04228042 | Completed | Phase 1/Phase 2 | Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer | July 28, 2020 | April 17, 2024 |
| NCT05775471 | Not yet recruiting | Phase 2 | Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer | June 1, 2024 | January 1, 2028 |
| NCT04628767 | Recruiting | Phase 2/Phase 3 | Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | November 12, 2021 | September 30, 2027 |
| NCT05564416 | Withdrawn | Phase 2 | Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial | October 12, 2023 | November 3, 2023 |